Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: Single Cell RNA sequence of clinical breast cancer stem-like cells

PROVIDER: PRJDB13903 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR394097_1.fastq.gz	Fastqsanger.gz
	DRR394097_2.fastq.gz	Fastqsanger.gz
	DRR394098_1.fastq.gz	Fastqsanger.gz
	DRR394098_2.fastq.gz	Fastqsanger.gz
	DRR394099_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 1152

Similar Datasets

GNPS - JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states

Project description:Inflammatory breast cancer (IBC) is a difficult-to-treat disease with poor clinical outcomes due to high risk of metastasis and resistance to treatment. We previously described a CD44+CD24-pSTAT3+ cancer cell subpopulation with stem cell-like features in breast cancer that is dependent on JAK/STAT3 signaling. Here we report that CD44+CD24- cells are the most frequent cell-type in IBC and are commonly pSTAT3+. Combination of JAK/STAT3 inhibition with paclitaxel decreased IBC xenograft growth more than either agent alone. We developed and characterized IBC cell lines resistant to paclitaxel and doxorubicin to mimic therapeutic resistance in patients. Multi-omic profiling of parental and resistant cells revealed genes associated with lineage identity and inflammation were enriched in chemotherapy resistant derivatives. Integrated pSTAT3 ChIP-seq and RNA-seq analyses showed pSTAT3 regulates genes related to inflammation and epithelial to mesenchymal transition (EMT) in resistant cells, as well as PDE4A, a cAMP-specific phosphodiesterase. Metabolomic characterization identified elevated cAMP signaling and CREB as a candidate therapeutic target in IBC. We also investigated cellular dynamics and heterogeneity at the single cell level during chemotherapy and acquired resistance by CyTOF and single cell RNA-seq. We identified mechanisms of resistance including a shift from luminal to basal/mesenchymal cell states through selection for rare pre-existing subpopulations or an acquired change. Lastly, we showed that combination treatment with paclitaxel and JAK/STAT3 inhibition prevented the emergence of this more mesenchymal chemo-resistant subpopulation. Our results provide mechanistic rational for combination of chemotherapy with inhibition of JAK/STAT3 signaling as a new more effective therapeutic strategy in IBC.

2022-11-04 | MSV000090647 | GNPS

Homo sapiens

Project description:Single-cell analysis reveals a stem cell program in human metastatic breast cancer cells (PDX mice - cancer cells)

| PRJNA289001 | ENA

Homo sapiens

Project description:Single cell RNA sequencing of primary breast cancer.

| PRJNA305054 | ENA

Homo sapiens

Project description:Single-cell RNA sequencing of infiltrated immune cells isolated from breast cancer

| PRJNA890914 | ENA

Homo sapiens

Project description:Breast cancer single cell sequencing

| PRJNA381307 | ENA

Homo sapiens

Project description:KDM4 inhibition targets breast cancer stem cells [RNA-Seq]

| PRJNA376575 | ENA

Homo sapiens

Project description:Single-cell analysis reveals a stem cell program in human metastatic breast cancer cells (Human patients - mammary cells)

| PRJNA289006 | ENA

Single-cell RNA sequencing on breast cancer cells enriched for cancer stem cell properties using functional assays

Project description:Single-cell RNA sequencing on breast cancer cells enriched for cancer stem cell properties using functional assays

| PRJNA514740 | ENA

Homo sapiens

Project description:Single-cell RNA sequencing of circulating epithelial cells in non-metastatic breast cancer patients

| PRJNA776403 | ENA

Homo sapiens

Project description:Cancer stem cells subpopulations within the CD44high human breast cancer stem cell compartment [HMT clones]

| PRJNA254953 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data